Related Experiment Video
Updated: Sep 26, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different
Liala Moschetti1, Silvia Piantoni1, Enrico Vizzardi2
1Rheumatology and Clinical immunology Unit, ASST Spedali Civili of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Systemic autoimmune diseases like lupus and scleroderma cause vascular damage, leading to higher cardiovascular mortality. Early detection of endothelial dysfunction is key for assessing cardiovascular risk in these patients.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Vascular Biology
Background:
- Systemic autoimmune diseases, including systemic lupus erythematosus and systemic sclerosis, are associated with significant cardiovascular morbidity and mortality.
- Vascular dysfunction, characterized by inflammation, vasculopathy, and fibrosis, contributes to endothelial stiffness and damage in affected patients.
- Despite advances in diagnostics and therapies, cardiovascular mortality remains elevated in these patient populations.
Purpose of the Study:
- To review the complex interplay of inflammation, vasculopathy, and fibrosis in cardiovascular and peripheral small vessel disease in systemic autoimmune diseases.
- To highlight the increased cardiovascular mortality observed in patients with systemic lupus erythematosus and systemic sclerosis.
- To provide an overview of novel techniques for preclinical evaluation of endothelial dysfunction for cardiovascular risk assessment.
Main Methods:
- Literature review of studies on vascular dysfunction in systemic autoimmune diseases.
- Analysis of mechanisms linking inflammation, vasculopathy, and fibrosis to vascular damage.
- Overview of emerging diagnostic techniques for endothelial dysfunction.
Main Results:
- Systemic lupus erythematosus and systemic sclerosis serve as distinct models of vascular dysfunction in systemic autoimmune diseases.
- Endothelial stiffness, vascular damage, and premature aging are consequences of the described pathobiology.
- New techniques allow for preclinical evaluation of endothelial dysfunction, offering potential for improved cardiovascular risk assessment.
Conclusions:
- Vascular dysfunction is a critical determinant of excess cardiovascular mortality in systemic autoimmune diseases.
- Early detection of endothelial dysfunction using novel methods may improve cardiovascular risk stratification.
- Further research into these mechanisms and diagnostic tools is warranted to mitigate cardiovascular complications.
More Related Videos
09:33A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Peripheral Artery Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome I : Introduction